Fact CheckerSign in

NCT07525856Not yet recruiting

Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis

Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis, a Multicentre Randomized Pilot Study

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

Canada urgently needs new ways to provide rheumatology care that improve treatment and make it easier for people to get high-quality care. E-health technology is a new and promising way to do this, but it hasn't been studied much yet in rheumatology. The investigators will test a new way to help people with rheumatoid arthritis at four clinics in Quebec. This study will check if the new approach is easy to use, fits well into the clinics' daily routine, and if both patients and healthcare workers find it helpful and acceptable. This new approach involves nurses helping patients check their own health from home using an online platform. 104 adults who have rheumatoid arthritis and who have had a flare-up or a change in their medication in the last three months, will participate. Some will start using the online self-monitoring tool right away for 16 months, while others will continue with their usual care for 8 months before trying the tool. During the time they use the tool, they will fill out monthly online questionnaires to check their health. A rheumatology nurse will review their answers, suggest any needed care, provide personalized health information, and be available to answer questions through messages. This new way of care, where nurses help patients monitor their rheumatoid arthritis from home, helps make better use of limited specialist time. It's more convenient for patients, especially those who live far away, and helps meet their needs between regular doctor visits while keeping the quality of care high.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
104 (estimated)
First submitted
25 Mar 2026
Start date
1 Jan 2027
Primary completion date
31 May 2028
Lead sponsor
CHU de Quebec-Universite Laval
NCT number
NCT07525856

What you commit to

  • Study type: Interventional
  • Planned participants: 104
  • From 1 Jan 2027 to the primary completion date, 31 May 2028
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Inability to consent
  • Inability to complete questionnaires
  • No Internet access

Who the study is looking for

  • Age ≥ 18 years
  • Diagnosis of rheumatoid arthritis (RA) according to the ACR 2010 criteria
  • Disease duration ≥ six months
  • Who experienced a flare defined by an increase of the clinical disease activity index (CDAI) ≥ 4.5 or a DMARDs switch or addition within the preceding three months
  • Understanding French or English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital general de Montreal
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status
Centre de l'ostéporose et de rhumatologie de Québec
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status
CHU de Quebec-Universite Laval
Coordinator of this site? Confirm its status
QuébecCanadaUnknown status
Hopital Fleurimont et Hotel Dieu de Sherbrooke
Coordinator of this site? Confirm its status
SherbrookeCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.